Patent · US Expired

Benzimidazole derivatives, a process for their manufacture and use as a medicine

US6855713B2 · kind B2 · utility

3Cited by

5References

14Claims

0Family size

Assignee

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

Pascale Pouzet · Biberach, DE
Christoph Hoenke · Ingelheim am Rhein, DE
Claudia Heine · Biberach, DE
Ralf Anderskewitz · Laupheim, DE
Horst Dollinger · Schemmerhofen, DE
Herbert Nar · Ochsenhausen, DE
Hans Michael Jennewein · Wiesbaden, DE
Bernd Disse · Ingelheim am Rhein, DE

Key dates

Filing date	Sep 9, 2002
Grant date	Feb 15, 2005
Priority date	—
Expiry date	Nov 16, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention concerns benzimidazole derivatives of the general formula (I) in which the radicals R1, R2, R3, X1 and A can have the meanings assigned to them in the specification, their prodrugs, processes for their production as well as the use of the benzimidazole derivatives as medicines, especially as medicines that have trypsin-inhibiting action.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.